These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19728405)

  • 1. Evaluation of a general practice based hepatitis C virus screening intervention.
    Anderson EM; Mandeville RP; Hutchinson SJ; Cameron SO; Mills PR; Fox R; Ahmed S; Taylor A; Spence E; Goldberg DJ
    Scott Med J; 2009 Aug; 54(3):3-7. PubMed ID: 19728405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention.
    Cullen BL; Hutchinson SJ; Cameron SO; Anderson E; Ahmed S; Spence E; Mills PR; Mandeville R; Forrest E; Washington M; Wong R; Fox R; Goldberg DJ
    J Public Health (Oxf); 2012 Mar; 34(1):14-23. PubMed ID: 22138489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.
    Hutchinson SJ; Roy KM; Wadd S; Bird SM; Taylor A; Anderson E; Shaw L; Codere G; Goldberg DJ
    Scott Med J; 2006 May; 51(2):8-15. PubMed ID: 16722130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population.
    McDonald SA; Hutchinson SJ; Mills PR; Bird SM; Robertson C; Dillon JF; Springbett A; Goldberg DJ
    Epidemiol Infect; 2010 Mar; 138(3):393-402. PubMed ID: 19723361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
    Grebely J; Genoway K; Khara M; Duncan F; Viljoen M; Elliott D; Raffa JD; DeVlaming S; Conway B
    Int J Drug Policy; 2007 Oct; 18(5):437-43. PubMed ID: 17854734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of injecting drug use status on hepatitis C-related referral and treatment.
    Stoové MA; Gifford SM; Dore GJ
    Drug Alcohol Depend; 2005 Jan; 77(1):81-6. PubMed ID: 15607844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them.
    Roy KM; Hutchinson SJ; Wadd S; Taylor A; Cameron SO; Burns S; Molyneaux P; McIntyre PG; Goldberg DJ
    Epidemiol Infect; 2007 Apr; 135(3):433-42. PubMed ID: 16893486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users.
    Gigi E; Sinakos E; Sykja A; Androulakis G; Tanis C; Stayridou V; Tsirogianni E; Zouridakis K; Bellou AL; Orfanou E; Raptopoulou-Gigi M
    J Addict Med; 2013; 7(1):52-7. PubMed ID: 23340710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection.
    McDonald SA; Hutchinson SJ; Bird SM; Robertson C; Mills PR; Dillon JF; Goldberg DJ
    Int J Drug Policy; 2011 Jan; 22(1):63-9. PubMed ID: 20472416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinfection with hepatitis C virus following sustained virological response in injection drug users.
    Grebely J; Knight E; Ngai T; Genoway KA; Raffa JD; Storms M; Gallagher L; Krajden M; Dore GJ; Duncan F; Conway B
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1281-4. PubMed ID: 20594256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W; Stanley J; Langton D; Kelly Y; Bury G
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland.
    Hutchinson SJ; Bird SM; Goldberg DJ
    Hepatology; 2005 Sep; 42(3):711-23. PubMed ID: 16116637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
    BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linkage into specialist hepatitis C treatment services of injecting drug users attending a needle syringe program-based primary healthcare centre.
    Islam MM; Topp L; Conigrave KM; White A; Reid SE; Grummett S; Haber PS; Day CA
    J Subst Abuse Treat; 2012 Dec; 43(4):440-5. PubMed ID: 22938915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examination of the risk of reinfection with hepatitis C among injecting drug users who have been tested in Glasgow.
    McDonald SA; Hutchinson SJ; Cameron SO; Innes HA; McLeod A; Goldberg DJ
    Int J Drug Policy; 2012 Sep; 23(5):353-7. PubMed ID: 22421553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted hepatitis C screening among ex-injection drug users in the community.
    Wong VW; Wong GL; Chim AM; Cheng TF; Cheung SW; Lai CM; Szeto KJ; Tsang S; Wu SH; Yan KK; Hui AY; Yiu DC; Wu BB; Cheung D; Chung CS; Lai CW; Chan HL
    J Gastroenterol Hepatol; 2014 Jan; 29(1):116-20. PubMed ID: 24033786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus antibody prevalence among injecting drug users in Glasgow has fallen but remains high.
    Goldberg D; Cameron S; McMenamin J
    Commun Dis Public Health; 1998 Jun; 1(2):95-7. PubMed ID: 9644121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration.
    Swan D; Long J; Carr O; Flanagan J; Irish H; Keating S; Keaveney M; Lambert J; McCormick PA; McKiernan S; Moloney J; Perry N; Cullen W
    AIDS Patient Care STDS; 2010 Dec; 24(12):753-62. PubMed ID: 21138381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.